Pharmaceutical

LP-184 by Starlight Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval

LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer.

Jul 6, 2024 - 04:00
LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer.
Read the original article

Tags:

Previous Article

ICTCAR-028 by Innovative Cellular Therapeutics for Hematological Tumor: Likeliho...

Next Article

Dalfampridine IR by Solaxa for Spinocerebellar Ataxia (SCA): Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bacterial Conjunctivitis drugs in development, 2023

Nov 30, 2023

IDE-161 by Ideaya Biosciences for Metastatic Ovarian Ca...

Dec 22, 2023

Emergent wins $75m BARDA contact for anthrax vaccine

Emergent wins $75m BARDA contact for anthrax vaccine

Nov 28, 2023